IDiyas

For the Inventor, By the Inventor

Westfield, NJ, United States of America

Robert E Schwartz

USPTO Granted Patents = 22 

Average Co-Inventor Count = 4.9

ph-index = 8

Forward Citations = 151(Granted Patents)


Location History:

  • Westfield, NJ (US) (1989 - 1995)
  • Scotch Plains, NJ (US) (1994 - 2002)

Company Filing History:

goldMedal22 out of 4,770 
 
Merck + Co., Inc.
 patents

Years Active: 1989-2002

Loading Chart...
22 patents (USPTO):
1. 6436395 - Rosellinia subiculata ATCC 74386 and fungus ATCC 74387 for producing sordarin compounds for fungi control (2002-08-20),
2. 5756472 - Antifungal agent obtained from hormonema (1998-05-26),
3. 5712109 - Antifungal agent produced by arthrinium arundinis ATCC 74359 (1998-01-27),
4. 5543431 - Anti-fungal agents (1996-08-06),
5. 5461071 - Anti-fungal agents (1995-10-24),
6. 5386009 - Lipopeptide derivatives (1995-01-31),
7. 5385884 - Lipopeptide derivatives (1995-01-31),
8. 5366880 - Antibiotic agent (1994-11-22),
9. 5348970 - Antifungal compound and compositions containing the compound (1994-09-20),
10. 5336756 - Process for crystalline cyclic lipopeptides (1994-08-09),
11. 5330973 - Lipopeptide derivatives (1994-07-19),
12. 5310873 - Cyclohexapeptide compound (1994-05-10),
13. 5306708 - Antibiotic agent (1994-04-26),
14. 5202309 - Antibiotic cyclopeptide fermentation product (1993-04-13),
15. 5194377 - Antibiotic agent (1993-03-16),

Title: The Innovative Contributions of Robert E. Schwartz

Introduction

Robert E. Schwartz, a distinguished inventor based in Westfield, NJ, has made significant strides in the field of antifungal solutions through his innovative patents. With a total of 22 patents to his name, Schwartz's work has made a considerable impact in agricultural biotechnology, particularly in combating plant diseases caused by fungi.

Latest Patents

Among Schwartz's latest patents are groundbreaking inventions related to controlling phytopathogenic fungi. His patents include the strains Rosellinia subiculata ATCC 74386 and fungus ATCC 74387, which are critical for producing sordarin compounds aimed at fungal control. The disclosed methods involve cultivating these strains in nutrient media rich in carbon and nitrogen sources, promoting the recovery of a sordarin compound. Additionally, Schwartz has introduced antifungal compositions that utilize these compounds, showcasing a novel compound derived from hormonema that exhibits significant antifungal activity.

Career Highlights

Schwartz's career is marked by his pivotal role at Merck & Company, Inc., where he has contributed to advancements in the pharmaceutical and agritech sectors. His expertise in developing antifungal agents has positioned him as a leading figure in the fight against agricultural diseases, ensuring healthier crops and more sustainable farming practices.

Collaborations

Throughout his career, Schwartz has collaborated with industry experts, including notable coworkers like Jerrold M. Liesch and Robert A. Giacobbe. These partnerships have not only fostered innovation but have also enhanced the efficacy and reach of the solutions developed within his team at Merck & Company, Inc.

Conclusion

With his extensive patent portfolio and collaborative efforts, Robert E. Schwartz continues to influence the landscape of agricultural technology. His innovative approaches to controlling fungal infections through specific strains and compounds reflect a commitment to enhancing crop health and food security. As he progresses in his career, the contributions of Schwartz promise to address pressing challenges in the agricultural sector.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…